Jejunal crypt cell abnormalities associated with methotrexate treatment in children with acute lymphoblastic leukaemia.

AUTOR(ES)

Pinkerton, C R

RESUMO

Jejunal mucosal crypts were examined in jejunal biopsies from eight children with acute lymphoblastic leukaemia who had recently received methotrexate treatment. By comparison with biopsies from children under investigation for suspected malabsorption crypt mitosis was significantly reduced and showed a negative correlation with the dose of methotrexate given prior to biopsy. The three major cell types were studied under light and transmission electron microscopy. Gut endocrine cells were unaffected by therapy and immature crypt enterocytes showed only patchy degenerative abnormalities. By contrast a number of Paneth cells showed striking structural alterations with vacuolar dilatation of the cytoplasm. The extent of this correlated with the time since methotrexate treatment rather than its dose and may have been a functional response rather than of a toxic nature.

Documentos Relacionados

• Immunoglobulin concentrations in children receiving treatment for acute lymphoblastic leukaemia.
• Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood.
• Morphological heterogeneity in childhood B cell acute lymphoblastic leukaemia.
• Myelodysplastic syndrome coexisting with acute lymphoblastic leukaemia.
• Measles encephalitis during immunosuppressive treatment for acute lymphoblastic leukaemia.